Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024
Compare Balance Sheet Results of Onyx Biotec
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
18.13
13.95
4.18
29.96%
Share Warrants & Outstandings
Total Reserve
37.49
9.11
28.38
311.53%
Shareholder's Funds
55.62
23.06
32.56
141.20%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.00
6.76
0.00%
Secured Loans
5.49
0.00
5.49
0.00%
Unsecured Loans
1.27
0.00
1.27
0.00%
Deferred Tax Assets / Liabilities
3.14
0.09
3.05
3,388.89%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
9.90
0.09
9.81
10,900.00%
Current Liabilities
Trade Payables
16.73
1.39
15.34
1,103.60%
Other Current Liabilities
3.30
0.61
2.69
440.98%
Short Term Borrowings
5.70
2.57
3.13
121.79%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
25.73
4.57
21.16
463.02%
Total Liabilities
91.25
27.73
63.52
229.07%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
40.90
9.39
31.51
335.57%
Less: Accumulated Depreciation
0.00
8.11
-8.11
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
40.90
1.28
39.62
3,095.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.57
-1.57
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
5.06
-5.06
-100.00%
Other Non Current Assets
1.16
7.26
-6.10
-84.02%
Total Non-Current Assets
42.06
15.17
26.89
177.26%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
16.10
4.41
11.69
265.08%
Sundry Debtors
20.23
6.31
13.92
220.60%
Cash and Bank
8.61
0.06
8.55
14,250.00%
Other Current Assets
4.07
1.08
2.99
276.85%
Short Term Loans and Advances
0.17
0.70
-0.53
-75.71%
Total Current Assets
49.19
12.56
36.63
291.64%
Net Current Assets (Including Current Investments)
23.46
7.99
15.47
193.62%
Total Current Assets Excluding Current Investments
49.19
12.56
36.63
291.64%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
91.25
27.73
63.52
229.07%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
12.46
2.57
9.89
384.82%
Book Value per share (adjusted)
30.68
16.53
14.15
85.60%
Annual - Borrowings
Borrowings 12.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -59.52% vs NA in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 40.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.93% vs NA in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 49.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.41% vs NA in Mar 2024






